Pluristem Therapeutics Inc. (PSTI): Technical Analysis and analyst Ratings


Pluristem Therapeutics Inc. (NASDAQ:PSTI) changes shares on Friday trading session, with a change of -3.40% or -$0.31 shares. The trading starts at $9.31 and closed at $9.11 throughout the day. The trading session low price was $8.40 and day high was $9.3241 on Friday, June 26. After the session, the Healthcare sector daily volume shifted to 0.51 million while its average volume is 2.37M. In other hand, the PSTI market cap reached to $210.94M.

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 14.88% and up 5.90% for month. Its quarterly performance was 192.36% above, while its half year performance is up 122.78%. PSTI yearly performance stood at positive 44.83% and rise 123.35% for year-to-date. Current recommendation for Pluristem Therapeutics Inc. is 1.70.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. PSTI EPS (TTM) for 12-month is -7.58. EPS for this year is 44.10%, while for the next year its value is -1.21. Its EPS Q/Q reached 51.00%. It has an EPS of -46.50% down for past five years.

The company posted an EPS (TTM) of -7.58. According to the most recent quarter report on (Jun 2020), 3 analysts estimated an average EPS of -0.34, while -0.63 EPS posted a year ago period. Analyst Estimated EPS for PSTI published in the report was -0.45–0.28 during the same period. Comparing with last year, the average estimated EPS was -0.63 which is lower than -0.42 which was posted for recent quarter EPS.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for PSTI rise 74.73% for period of 200 days. SMA for 50 days was 1.63% which is showing green signal, while SMA-20 was 13.92%. The moving average value for Pluristem Therapeutics Inc. (PSTI) is 5.70 and 8.28 for 200 and 50 days respectively.